CRIS CURIS INC

Nasdaq curis.com


$ 1.53 $ -0.02 (-1.28 %)    

Friday, 17-Oct-2025 15:59:52 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.54
$ 1.55
$ 1.52 x 10
$ 1.68 x 395
$ 1.52 - $ 1.57
$ 1.02 - $ 5.45
40,490
na
19.25M
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-08-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-13-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-16-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-12-2020 03-31-2020 10-Q
23 03-19-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 03-26-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-03-2018 03-31-2018 10-Q
31 03-08-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 03-09-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 curis-q2-eps-068-beats-136-estimate-sales-275m-beat-264m-estimate

Curis (NASDAQ:CRIS) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(1.36) by 50 p...

 a-peek-at-curiss-future-earnings
A Peek at Curis's Future Earnings
08/04/2025 21:04:09

 curis-announces-7m-registered-direct-offering-and-private-placement-selling-154m-shares-at-2275-each-the-combined-purchase-price-for-1-share-and-the-associated-common-warrant-is-2275-combined-purchase-price-for-1-pre-funded-warrant-and-the-associated-common-warrant-is-2265

Curis, Inc. ("Curis") (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an or...

 hc-wainwright--co-assumes-curis-at-buy-announces-price-target-of-17

HC Wainwright & Co. analyst Joseph Pantginis assumes Curis (NASDAQ:CRIS) with a Buy rating and announces Price Target of...

 earnings-outlook-for-curis
Earnings Outlook For Curis
05/05/2025 20:02:50

 hc-wainwright--co-maintains-buy-on-curis-lowers-price-target-to-16

HC Wainwright & Co. analyst Edward White maintains Curis (NASDAQ:CRIS) with a Buy and lowers the price target from $20 t...

 hc-wainwright--co-reiterates-buy-on-curis-maintains-20-price-target

HC Wainwright & Co. analyst Edward White reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $20 price target.

 hc-wainwright--co-reiterates-buy-on-curis-maintains-20-price-target

HC Wainwright & Co. analyst Edward White reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $20 price target.

 curis-q3-2024-gaap-eps-170-beats-183-estimate-cash-and-cash-equivalents-of-316m-is-expected-to-provide-cash-runway-into-mid-2025

Curis (NASDAQ:CRIS) reported quarterly losses of $(1.70) per share which beat the analyst consensus estimate of $(1.83) by 7.1 ...

 curis-13g-filing-shows-thomas-a-satterfield-jr-reported-a-805-stake-in-the-co-as-of-october-30-2024

- SEC Filing 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION